A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
NCT07136805
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
152
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-infectious Anterior Uveitis
Interventions
DRUG:
VVN461 Ophthalmic Solution 1.0%
DRUG:
1.0% prednisolone acetate
Sponsor
VivaVision Biotech, Inc